Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder.
- DOI
- 10.1097/adm.0000000000001320
- Published
- 2024 Sep-Oct 01
- Container
- Journal of addiction medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/adm.0000000000001320,
title = {Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder.},
author = {Reddy IA and Audet CM and Reese TJ and Peek G and Marcovitz D},
year = {2024},
journal = {Journal of addiction medicine},
doi = {10.1097/adm.0000000000001320},
url = {https://doi.org/10.1097/adm.0000000000001320}
}RIS
TY - JOUR TI - Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder. AU - Reddy IA AU - Audet CM AU - Reese TJ AU - Peek G AU - Marcovitz D PY - 2024 JO - Journal of addiction medicine DO - 10.1097/adm.0000000000001320 UR - https://doi.org/10.1097/adm.0000000000001320 ER -
APA
IA, R., CM, A., TJ, R., G, P., & D, M. (2024). Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder.. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001320
Source records
- pubmed · retrieved 2026-09-26T19:20:04.266Z